699
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Knockdown of miR-1275 protects against cardiomyocytes injury through promoting neuromedin U type 1 receptor

, , , , , & show all
Pages 3639-3649 | Received 06 Dec 2019, Accepted 02 Nov 2020, Published online: 15 Dec 2020

References

  • Vaage J, Valen G. Pathophysiology and mediators of ischemia-reperfusion injury with special reference to cardiac surgery: a review. Scand J Thorac Cardiovasc Surg Suppl. 1993;41:1–18.
  • Zschirnt M, Jux C, Boenig H, et al. Neonatal myocardial infarction: substantial improvement of cardiac function after autologous bone marrow-derived cell therapy. Clin Res Cardiol. 2019;108:1309–1311.
  • Solevåg AL, Schmölzer GM, Cheung PY. Right ventricular myocardial ischemia with arrhythmia in an asphyxiated newborn. Ajp Rep. 2016;6:e203–e205.
  • Hausenloy DJ, Yellon DM. Targeting myocardial reperfusion injury — the search continues. N Engl J Med. 2015;373:1073–1075.
  • Gao Y, Huang R, Chen R, et al. Ischemic postconditioning altered MicroRNAs in human valve replacement. J Surg Res. 2015;200:28-35.
  • Jiang C, Liu X, Wang M, et al. High blood miR-802 is associated with poor prognosis in HCC patients by regulating DNA damage response 1 (REDD1)-mediated function of T cells. Oncol Res Featuring Preclinical Clin Cancer Ther. 2019;27:1025–1034.
  • Montgomery RL, Hullinger TG, Semus HM, et al. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation. 2011;124:1537–1547.
  • Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol. 2007;23:175–205.
  • Biasucci LM, Cardillo MT. MicroRNA and myocardial infarction *. 2013;999–1001.
  • Jing S, Yihua B, Xiangqing K, et al. miR-17-3p contributes to exercise-induced cardiac growth and protects against myocardial ischemia-reperfusion injury. Theranostics. 2017;7:664–676.
  • Wang Y, Men M, Yang W, et al. MiR-31 downregulation protects against cardiac ischemia/reperfusion injury by targeting protein kinase C epsilon (PKCe) directly. Cell Physiol Biochem. 2015;36:179–190.
  • Yao L, Lv X, Wang X. MicroRNA 26a inhibits HMGB1 expression and attenuates cardiac ischemia-reperfusion injury. J Pharmacol Sci. 2016;131:6–12.
  • Park KM, Teoh JP, Wang Y, et al. Carvedilol-responsive microRNAs, miR-199a-3p and −214 protect cardiomyocytes from simulated ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2016;311:ajpheart.00807.2015.
  • Fawzy IO, Hamza MT, Hosny KA, et al. miR‐1275: a single microRNA that targets the three IGF2‐mRNA‐binding proteins hindering tumor growth in hepatocellular carcinoma. FEBS Lett. 2016;589:2257–2265.
  • Ma X, Yang X, Bao W, et al. Circular RNA circMAN2B2 facilitates lung cancer cell proliferation and invasion via miR-1275/FOXK1 axis. Biochem Biophys Res Commun. 2018;498:1009–1015.
  • Kaiyu S, Zhe C, Cen Z, et al., Otorhinolaryngology DO. Effects of miR-1275 and its target gene HOXB5 on nasopharyngeal carcinoma cells. Med J Wuhan Univ. 2018;39:910–913.
  • Pang L, You L, Ji C, et al. miR-1275 inhibits adipogenesis via ELK1 and its expression decreases in obese subjects. J Mol Endocrinol. 2016;57:33.
  • Zhou YF, Fu ZY, Chen XH, et al. Tumor necrosis factor‑α and interleukin‑6 suppress microRNA‑1275 transcription in human adipocytes through nuclear factor‑κB. Mol Med Rep. 2017;16:5965-5971.
  • Gu H, Chen L, Xue J, et al. Expression profile of maternal circulating microRNAs as non-invasive biomarkers for prenatal diagnosis of congenital heart defects. Biomed Pharmacother.2019;109:823-830.
  • O’Brien JE, Kibiryeva N, Zhou XG, et al. Noncoding RNA expression in myocardium from infants with tetralogy of fallot. Circ Cardiovasc Genet. 2012;5:279–286.
  • Ma Q, Zhao H, Tao Z, et al. MicroRNA-181c exacerbates brain injury in acute ischemic stroke. Aging Dis. 2016;7:705–714.
  • Meng Y, Li W-Z, Shi Y-W, et al. Danshensu protects against ischemia/reperfusion injury and inhibits the apoptosis of H9c2 cells by reducing the calcium overload through the p-JNK-NF-κB-TRPC6 pathway. Int J Mol Med. 2016;37:258–266.
  • Fauconnier J, Roberge S, Saint N, et al. Type 2 ryanodine receptor: a novel therapeutic target in myocardial ischemia/reperfusion. Pharmacol Ther. 2013;138:323–332.
  • Ramachandran S, Lowenthal A, Ritner C, et al. Plasma microvesicle analysis identifies microRNA 129-5p as a biomarker of heart failure in univentricular heart disease. PLoS ONE. 2017;12:e0183624.
  • Yoo H, Kim Y, Lee Y, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Investig. 2001;108:407–414.
  • Zhang S, Zhang R, Wu F, et al. MicroRNA-208a regulates H9c2 cells simulated ischemia-reperfusion myocardial injury via targeting CHD9 through Notch/NF-kappa B signal pathways. Int Heart J. 2018;59:580–588.
  • Zhu W, Liu F, Wang L, et al. pPolyHb protects myocardial H9C2 cells against ischemia-reperfusion injury by regulating the Pink1-Parkin-mediated mitochondrial autophagy pathway. Artif Cells Nanomed Biotechnol. 2019;47:1248–1255.
  • Park S, Choe M, Yeo H, et al. Yes‐associated protein mediates human embryonic stem cell‐derived cardiomyocyte proliferation: involvement of epidermal growth factor receptor signaling. J Cell Physiol. 2018;233:7016–7025.
  • Pereira L, Dan JB, Galice S, et al. β-Adrenergic induced SR Ca2+ leak is mediated by an Epac-NOS pathway. J Mol Cell Cardiol. 2017;108:8.
  • Cao C, Li L, Li H, et al. Cyclic biaxial tensile strain promotes bone marrow-derived mesenchymal stem cells to differentiate into cardiomyocyte-like cells by miRNA-27a. Int J Biochem Biotechnol. 2018;99:125-132.
  • Muchtar E, Dispenzieri A, Lacy MQ, et al. Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation. Br J Haematol. 2017;178:888–895.
  • Ghasemibasir H, Heidarpour M, Emami F, et al. Evaluation of total-LDH/heat resistant-LDH ratio in patients with acute myocardial infarction and unstable pectoral angina. J Shahrekord Univ Med Sci. 2009.
  • Young GP, Gibler WB, Hedges JR, et al. Serial creatine kinase-MB results are a sensitive indicator of acute myocardial infarction in chest pain patients with nondiagnostic electrocardiograms: the second emergency medicine cardiac research group study. Acad Emerg Med. 2014;4:869–877.
  • Ganguly R, Hasanally D, Stamenkovic A, et al. Alpha linolenic acid decreases apoptosis and oxidized phospholipids in cardiomyocytes during ischemia/reperfusion. Mol Cell Biochem. 2018;437:163–175.
  • Santana LF, Gómez AM, Kranias EG, et al. Amount of calcium in the sarcoplasmic reticulum: influence on excitation-contraction coupling in heart muscle. Heart Vessels Suppl. 1997;12:44–49.
  • Bers DM. Cardiac sarcoplasmic reticulum calcium leak: basis and roles in cardiac dysfunction. Annu Rev Physiol. 2013;76:107.
  • Bertero E, Maack C. Calcium signaling and reactive oxygen species in mitochondria. Circ Res. 2018;122:1460–1478.
  • Humeau J, Bravo-San Pedro JM, Vitale I, et al. Calcium signaling and cell cycle: progression or death. Cell Calcium. 2018;70:3–15.
  • Kaczmarek P, Malendowicz L, Pruszynska-Oszmalek E, et al. Neuromedin U receptor 1 expression in the rat endocrine pancreas and evidence suggesting neuromedin U suppressive effect on insulin secretion from isolated rat pancreatic islets. Int J Mol Med. 2006;18:951–955.
  • Schiano C, Costa V, Aprile M, et al. Heart failure: pilot transcriptomic analysis of cardiac tissue by RNA-sequencing. Cardiol J. 2017;24:539–553.
  • Nathan D, Roe JR. Oxidative activation of Ca2+/calmodulin-activated kinase II mediates ER stress-induced cardiac dysfunction and apoptosis. Am J Physiol Heart Circ Physiol. 2013;304:H828.
  • Zhang Y, Jiang D, Zhang J, et al. Activation of neuromedin U type 1 receptor inhibits L-type Ca2+ channel currents via phosphatidylinositol 3-kinase-dependent protein kinase C epsilon pathway in mouse hippocampal neurons. Cell Signal. 2010;22:1660–1668.
  • Respress JL, Oort RJV, Li N, et al. Role of RyR2 phosphorylation at S2814 during heart failure progression. Circ Res. 2012;110:1474.
  • Carlo MND, Said M, Ling H, et al. CaMKII-dependent phosphorylation of cardiac ryanodine receptors regulates cell death in cardiac ischemia/reperfusion injury. J Mol Cell Cardiol. 2014;74:274–283.
  • Menick DR, Renaud L, Buchholz A, et al. Regulation of Ncx1 gene expression in the normal and hypertrophic heart. Ann N Y Acad Sci. 2010;1099:195–203.
  • Guo Z, Wang S, Jiao Q, et al. RNAi targeting ryanodine receptor 2 protects rat cardiomyocytes from injury caused by simulated ischemia-reperfusion. Biomed Pharmacother. 2010;64:184–190.
  • Zhang DW, Bian ZP, Xu JD, et al. Astragaloside IV alleviates hypoxia/reoxygenation-induced neonatal rat cardiomyocyte injury via the protein kinase a pathway. Pharmacology. 2012;90:95–101.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.